By OAN Newsroom American pharmaceutical giant ‘Pfizer‘ has enrolled more than 42,000 people in its phase two trial of its potential COVID-19 vaccine. The company…
By OAN Newsroom American pharmaceutical giant ‘Pfizer‘ has enrolled more than 42,000 people in its phase two trial of its potential COVID-19 vaccine. The company…